DE2426106A1 - Arzneipraeparat mit antiphlogistischer wirkung zur oralen verabfolgung - Google Patents

Arzneipraeparat mit antiphlogistischer wirkung zur oralen verabfolgung

Info

Publication number
DE2426106A1
DE2426106A1 DE19742426106 DE2426106A DE2426106A1 DE 2426106 A1 DE2426106 A1 DE 2426106A1 DE 19742426106 DE19742426106 DE 19742426106 DE 2426106 A DE2426106 A DE 2426106A DE 2426106 A1 DE2426106 A1 DE 2426106A1
Authority
DE
Germany
Prior art keywords
glutamine
acid
acetylsalicylic acid
effect
animals
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
DE19742426106
Other languages
German (de)
English (en)
Inventor
Susumu Okabe
Keijiro Takagi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
KH Neochem Co Ltd
Original Assignee
Kyowa Hakko Kogyo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP6148773A external-priority patent/JPS5012221A/ja
Priority claimed from JP13957773A external-priority patent/JPS5089518A/ja
Priority claimed from JP13957873A external-priority patent/JPS5089519A/ja
Application filed by Kyowa Hakko Kogyo Co Ltd filed Critical Kyowa Hakko Kogyo Co Ltd
Publication of DE2426106A1 publication Critical patent/DE2426106A1/de
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/618—Salicylic acid; Derivatives thereof having the carboxyl group in position 1 esterified, e.g. salsalate
    • A61K31/621—Salicylic acid; Derivatives thereof having the carboxyl group in position 1 esterified, e.g. salsalate having the hydroxy group in position 2 esterified, e.g. benorylate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE19742426106 1973-06-01 1974-05-29 Arzneipraeparat mit antiphlogistischer wirkung zur oralen verabfolgung Pending DE2426106A1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP6148773A JPS5012221A (fr) 1973-06-01 1973-06-01
JP13957773A JPS5089518A (fr) 1973-12-17 1973-12-17
JP13957873A JPS5089519A (fr) 1973-12-17 1973-12-17

Publications (1)

Publication Number Publication Date
DE2426106A1 true DE2426106A1 (de) 1975-01-02

Family

ID=27297523

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19742426106 Pending DE2426106A1 (de) 1973-06-01 1974-05-29 Arzneipraeparat mit antiphlogistischer wirkung zur oralen verabfolgung

Country Status (4)

Country Link
CA (1) CA1029660A (fr)
DE (1) DE2426106A1 (fr)
FR (1) FR2231386B1 (fr)
GB (1) GB1460108A (fr)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4994457A (en) * 1985-10-02 1991-02-19 Pfizer Inc. Antiinflammatory compositions and methods
US5437571A (en) * 1992-08-14 1995-08-01 Ryobi North America, Corp. Detail sander
US5470272A (en) * 1994-02-03 1995-11-28 Ryobi Motor Products Corp. Removable working tool assembly
US5637034A (en) * 1993-08-13 1997-06-10 Ryobi North America, Inc. Detail sander
US5833524A (en) * 1994-08-22 1998-11-10 Ryobi Limited Dust collection system for a power tool

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8607662D0 (en) * 1986-03-27 1986-04-30 Rainsford K D Pharmaceutical formulation
GB8929076D0 (en) * 1989-12-22 1990-02-28 Scras Treatment of shock by blocking agents of edrf effect or formation
DE10158039A1 (de) * 2001-11-27 2003-07-03 Kosmas Kg Antiphlogistisches Mittel und dessen Verwendung

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2105111B1 (fr) * 1970-09-28 1974-03-22 Sogeras

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4994457A (en) * 1985-10-02 1991-02-19 Pfizer Inc. Antiinflammatory compositions and methods
US5437571A (en) * 1992-08-14 1995-08-01 Ryobi North America, Corp. Detail sander
US5637034A (en) * 1993-08-13 1997-06-10 Ryobi North America, Inc. Detail sander
US5470272A (en) * 1994-02-03 1995-11-28 Ryobi Motor Products Corp. Removable working tool assembly
US5833524A (en) * 1994-08-22 1998-11-10 Ryobi Limited Dust collection system for a power tool

Also Published As

Publication number Publication date
CA1029660A (fr) 1978-04-18
FR2231386B1 (fr) 1977-11-04
FR2231386A1 (fr) 1974-12-27
GB1460108A (en) 1976-12-31

Similar Documents

Publication Publication Date Title
DE69623634T2 (de) Pharmazeutische zusammensetzung von l-dopa ethyl ester
DE69110561T2 (de) Mittel zur Behandlung und Vorbeugung von Bauchentzündungen, die als Wirkstoff Zink-L-Carnosin-Salze oder -Komplexe enthalten.
DE69912790T2 (de) Farnesyl protein transferase inhibitoren zur behandlung von arthropathien
DE60101968T2 (de) Kristallform alpha des perindopril-tert-butylaminsalzes
US3988466A (en) Prevention of gastric lesions
DE69718662T2 (de) Magnesium(-)hydroxycitrat, verfahren zur herstellung, anwendung und pharmazeutische zusammensetzungen, die sie enthalten
DE3725176A1 (de) Pharmazeutische zusammensetzung mit analgetischer aktivitaet
DE3438455A1 (de) L-lysin- und l-histidinpyruvat
DE2426106A1 (de) Arzneipraeparat mit antiphlogistischer wirkung zur oralen verabfolgung
EP0552657A1 (fr) Utilisation de l'acide boswellique pur
DE1668930A1 (de) Neue Alkylaminopropanole und ihre Salze mit Saeuren,Verfahren zu ihrer Herstellung sowie therapeutische Mittel
DE2624558A1 (de) Arzneimittel mit analgetischer wirkung
EP0649654B1 (fr) Utilisation d'une association d'un inhibiteur ace avec un antagoniste du calcium pour traiter la protéinurie
DD238920A5 (de) Verfahren zur herstellung einer verbesserten entzuendungshemmend wirkenden zusammensetzung
EP0689837A2 (fr) Médicaments anti-hyperglycémiques
DE1767163A1 (de) Pharmazeutisches Praeparat
DE69807745T2 (de) Monoargininylsalz der (e)-3-[1-n-butyl-5-[(2-(2-carboxyphenyl)methoxy-4-chlorphenyl]-1h-pyrazol-4-yl]-2-[(5-methoxy-2,3-dihydrobenzofuran-6-yl)methyl]-prop-2-en carbonsäure
DE60112719T2 (de) Zusammensetzung enthaltend einen inhibitor der signaltransduktion von heterometrischen g proteinen in kombination mit einem antihypertensiven mittel zu einer therapeutischen verwendung in der behandlung von arterieller hypertonie
CH655243A5 (de) Arzneimittelkombination und verfahren zu ihrer herstellung.
AT408718B (de) Natriumvalproat-granulat mit verringerter hygroskopizität
DE2705817A1 (de) Neue anti-hypertonische zubereitungen mit gehalt an phenylhydrazinpropionsaeure und blutdrucksenkendem mittel
EP0880967B1 (fr) Médicament néphroprotecteur
DE3028927C2 (de) Azoverbindungen enthaltendes pharmazeutisches Mittel
DE60311134T2 (de) Oromukosale formulierung und herstellungsverfahren dafür
DE69007352T2 (de) (Alfa-t-butyl aminomethyl-3,4-dichlorobenzyl) thioacetamid, Verfahren zu ihrer Herstellung und ihre Verwendung.